Timothy A Springer bought $8.6M of TECX
director, owner at AVROBIO, Inc.. 500,000 shares at an average of $17.10, traded Apr 7, 2025, filed Apr 9, 2025.
Score components
- +15RoleDirector
- +25Trade size$8.6M at market
- +3Relative to holdingsHoldings up 12%
- +18Price context0% above the 52-week low; 72% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (2 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +17.3%, 3m +28.0%, 6m -8.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-010499, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 7, 2025 | POpen-market purchase Common Stock | +87,500 | $17.10 | $1.5M | 4,313,558 | Apr 9, 2025 |
| Apr 7, 2025 | POpen-market purchase Common Stockindirect: By LLC | +412,500 | $17.10 | $7.1M | 1,382,723 | Apr 9, 2025 |
Related signals
Other insiders at AVROBIO, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | AVROBIO, Inc. | Peter McNamara Chief Scientific Officer | $12k 536 shares | -1% | |
| 0Weak | AVROBIO, Inc. | Peter McNamara Chief Scientific Officer | $1,570 43 shares | -0% | |
| 0Weak | AVROBIO, Inc. | Peter McNamara Chief Scientific Officer | $1,505 43 shares | -0% | |
| 0Weak | AVROBIO, Inc. | Peter McNamara Chief Scientific Officer | $6,020 172 shares | -0% | |
| 0Weak | AVROBIO, Inc. | Marcella K. Ruddy Chief Medical Officer | $32k 1,065 shares | -2% | |
| 0Weak | AVROBIO, Inc. | Marcella K. Ruddy Chief Medical Officer | $31k 1,000 shares | -1% | |
| 5Weak | AVROBIO, Inc. | Peter McNamara Chief Scientific Officer | $189k 6,262 shares | -10% | |
| 22Weak | AVROBIO, Inc. | Marcella K. Ruddy Chief Medical Officer | $300k 10,000 shares | -13% | |
| 12Weak | AVROBIO, Inc. | Peter McNamara Chief Scientific Officer | $78k 3,299 shares | -8% | |
| 48Moderate | AVROBIO, Inc. | Alise Reicin Chief Executive Officer | $53k 2,500 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.